Mast cell and eosinophil mediated damage in bullous pemphigoid.
Goldstein
S M
SM
Veterans Administration Medical Center, San Francisco, California.
Wasserman
S I
SI
Wintroub
B U
BU
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use; D002630:Chemotactic Factors / Q000378:metabolism; D003167:Complement Activation; D015777:Eicosanoids / Q000378:metabolism; D004798:Enzymes / Q000378:metabolism; D004804:Eosinophils / Q000378:metabolism / Q000473:pathology*; D006636:Histamine Release; D006801:Humans; D008407:Mast Cells / Q000378:metabolism / Q000473:pathology*; D008954:Models, Biological; D010391:Pemphigoid, Bullous / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D010972:Platelet Activating Factor / Q000378:metabolism; D012867:Skin / Q000473:pathology
D000305:Adrenal Cortex Hormones; D002630:Chemotactic Factors; D015777:Eicosanoids; D004798:Enzymes; D010972:Platelet Activating Factor